Yersinia pestis, the causative agent of plague, is thought to be one of the most dangerous and deadly pathogenic bacteria in the world: it is classified by the Center for Disease Control and Prevention of the USA (CDC) (http://www.bt.cdc.gov/ agent/agentlist-category.asp) as a category A agent in the list of potential biowarfare or bioterrorism agents. Plague has been responsible for the loss of about 200 million lives throughout history. Even now, the World Health Organization receives at least 2000 plague case reports annually (WHO, 2004; Zhou et al., 2006) . Naturally occurring and genetically engineered antibiotic-resistant Y. pestis strains increase our concerns about the threat of its misuse as a biological weapon or bioterrorism agent. Thus, there is an urgent need for improved treatments and detection methods. The inherent binding specificity and lytic action of bacteriophages make them useful tools and targets for the diagnosis and treatment of plague. Nevertheless, there are few reports of the genetic analysis of the lytic phages of Y. pestis. About 33 lytic Y. pestis phages have been identified (Garcia et al., 2008) of which only three have been fully sequenced: Berlin (GenBank accession no. AM183667), Yepe2 (GenBank accession no. EU734170) and WA1122 (GenBank accession no. AY247822). We did not include bacteriophages L-413C (GenBank accession no. NC_004745) or PY100 (GenBank accession no. AM076770) in our analysis because L-413C is a temperate Y. pestis phage and PY100 is a lytic bacteriophage with a broad host range within the genus Yersinia, and they belong to the family Myoviridae. Berlin, Yepe2 and WA1122 belong to the family Podoviridae, morphotype C1, and the common phages T3 (GenBank accession no. NC_003298) and T7 (GenBank accession no. NC_001604) are also included in this family (Garcia et al., 2008) . Garcia et al. (2003) first provided a detailed description of WA1122, which is employed as a diagnostic agent for the causative agent of plague by the CDC (Garcia et al., 2003 
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Journal of General Virology 92 between two yersiniophages: one phage is closely related to the Yersinia enterocolitica phage WYeO3-12, and the second is either the Y. pestis phage WA1122 itself or an extremely close relative (Garcia et al., 2003) . The genome sequences of Berlin and Yepe2 were submitted to the GenBank/EMBL/ DDBJ databases in 2006 by Dr Noelting and colleagues and in 2008 by Dr Savalia and colleagues, respectively. Analysis of the sequences revealed that the phages belong to the T7 family and the genomes are collinear with those of T7, T3 and WYeO3-12.
There are several epidemic foci of Y. pestis in China and the bacteriophage Yep-phi is routinely used as a diagnostic agent for Y. pestis in China. The phage forms clear plaques at 26 u C on all strains of Y. pestis isolated in China. Its genome sequence and proteomics were determined in this report to analyse its relationship to the other three sequenced lytic Y. pestis phages and to lay the foundation for phage therapeutics. Methods of phage DNA isolation, genome sequencing and proteomics analysis are described in Supplementary Material (available in JGV Online).
The complete nucleotide sequence of Yep-phi is 38 616 bp of linear dsDNA and contains no RNA genes. It has a G+C content of 47.12 mol%, which is similar to that of its host Y. pestis (47.6 mol%) and to that of Yepe2 (47.27 mol%) Yersinia pestis phage sequence and proteomics and Berlin (47.19 mol%). For comparison, the G+C contents of WA1122 and T7 are 48.3 and 48.4 mol%, respectively, while that of T3 is 49.9 mol%. In total, 45 gene products were predicted in the Yep-phi genome; functions were assigned to 38 of them based on the similarities of the predicted products to known proteins.
Unlike the high nucleotide identity of WA1122 to T7 (89.1 %) and that of WYeO3-12 to T3 (85.2 %), the genome of Yep-phi is highly similar to the 38 564 bp of Berlin (98 %) and the 38 677 bp of Yepe2 (95.9 %) phages, with only 61 % identity to T7 and 60.5 % identity to T3. At the genome-wide level, the similarity between them prompted us to classify the Berlin, Yepe2 and Yep-phi as the Yep-phi subgroup and WA1122 as the other subgroup (Supplementary Figs S1 and S2, available in JGV Online). A description of the annotated genes of the four Y. pestis phages and their similarities to Yep-phi genes are summarized in Table 1 . Fig. 1 shows a comparative analysis of the four lytic phages' genomes, indicating that there are some differences amongst them.
All four Y. pestis phages mentioned above have head and tail genes in the same relative positions. Furthermore, the four phages all contain direct repeats at both termini of the mature DNAs. These terminal repeats (TR) are genetic elements known or suggested to be involved in DNA replication (Garcia et al., 2003) . The TRs of Berlin are very similar to those of Yepe2 but are 43 bp shorter. When the non-consecutive indels were removed, those of Berlin and Yepe2 share about 75 % identity. TRs of Yep-phi are more similar to those of Berlin (99 % identical), except for an 11 bp deletion and a 7 bp augmentation. Comparatively, those of T3 and WYeO3-12 share 89 % identity; those of WA1122 are 95 % identical to T7, except for a 13 bp deletion.
Bioinformatics analysis of the Yep-phi genome suggested that the region from ORF27 to ORF38 harbours most of the genes that encode proteins for building the mature virion particle. Liquid chromatography-mass spectrometry analysis identified most of the structural proteins of Yepphi. The sequence coverage and the number of identified peptides are provided in Supplementary Table S1 (available in JGV Online). The identified Yep-phi proteins, i.e. those encoded by ORF27 (internal head protein), ORF29 (headto-tail joining protein), ORF30 (capsid assembly protein), ORF31 (major capsid protein), ORF34 (internal virion protein A), ORF35 (internal virion protein B), ORF36 (internal virion protein C) and ORF37 (internal virion protein D), form the capsid. The ORFs identified to encode the tail proteins include ORF28 (tail assembly protein), ORF32 (tail tubular protein A), ORF33 (tail tubular protein B) and ORF38 (tail fibre protein). Recent studies on the attachment of short non-contractile phages to bacteria and lipopolysaccharide indicate that an endoglycosidase located in the phage tail is involved (Lindberg, 1973) . The internal head protein is an essential component of the phage particle in T7 (Garcia et al., 2003) . It is injected from the virion into the host cell and may be involved in virion morphogenesis.
Homologous recombination is a powerful source of genetic variability and a potent evolutionary mechanism for closely related bacteriophages (Varsani et al., 2006) . Here, a range of methods was applied to the full genome sequences of the Yep-phi group to provide evidence that recombination could occur. We employed RDP (Martin & Rybicki, 2000) , GENECONV (Padidam et al., 1999) , BOOTSCAN (Martin et al., 2005) , MAXIMUM 62 (Smith, 1992) , CHIMAERA (Martin et al., 2005) , 3SEQ (Boni et al., 2007) and SISCAN (Gibbs et al., 2000) methods incorporated in the RDP3 Beta42 program (Martin et al., 2005) . Recombination analysis Fig. 2 . Characterization of recombination events detected amongst the Yep-phi subgroup's full-genome sequences. Sequences bounded by recombination breakpoints are shaded on the graphical representation of the genomes. Breakpoint positions represent the boundaries of the strongest recombination signal, but are not necessarily at, or even close to, the breakage sites that occurred during the original recombination event. 'Minor' and 'major' parents refer to the parental sequences that contributed to the smaller and larger fractions of the recombinant's sequence, respectively. In the evidence column, letters represent methods indicating the presence of recombination: R, RDP; G, GENECONV; B, BOOTSCAN; M, MAXIMUM ¾2; C, CHIMAERA; 3, 3SEQ; S, SISCAN. X. Zhao and others detected four potential recombination events in the Yepphi subgroup (Fig. 2) .
As epizootic infections of bacteria, bacteriophages would seem to be good candidates for antibacterial therapy and prophylaxis. Ceaseless emergence of new antibiotic resistance mechanisms challenges antibiotic therapeutics, and phage therapy is now being re-evaluated as a means to treat or prevent bacterial infections worldwide (Labrie et al., 2010) . These phages do not contain any toxin genes that might be critical for preventing their application, indicating that phages could be developed as a means of treating pathogenic bacteria.
In summary, comparative genomics analysis identified two distinct subgroups among the four lytic bacteriophages for Y. pestis, and genetic recombination analysis indicated four potential recombination events among the Yep-phi subgroup. Our analysis could lay a foundation for understanding these phages' biological nature.
